These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7517384)

  • 1. Diagnostic and clinical implications of the different genotypes of hepatitis C virus.
    Bukh J; Miller RH
    Hepatology; 1994 Jul; 20(1 Pt 1):256-9. PubMed ID: 7517384
    [No Abstract]   [Full Text] [Related]  

  • 2. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of specific antibody assay for genotyping of hepatitis C virus.
    Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
    Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients.
    Lok AS; Chien D; Choo QL; Chan TM; Chiu EK; Cheng IK; Houghton M; Kuo G
    Hepatology; 1993 Sep; 18(3):497-502. PubMed ID: 7689528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic heterogeneity of the NS3 proteins in hepatitis C virus genotypes 1 and 6.
    Qiao W; Xie P; Cai B; Li L
    Intervirology; 2011 Feb; 54(2):53-60. PubMed ID: 20829600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
    Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
    Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of HCV-ELISA using synthetic peptide].
    Takahashi T; Hayashi N; Shikata T
    Nihon Rinsho; 1991 Feb; 49(2):347-50. PubMed ID: 1849192
    [No Abstract]   [Full Text] [Related]  

  • 9. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.
    Ferrari C; Valli A; Galati L; Penna A; Scaccaglia P; Giuberti T; Schianchi C; Missale G; Marin MG; Fiaccadori F
    Hepatology; 1994 Feb; 19(2):286-95. PubMed ID: 8294086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic tests: Hepatitis C virus-related antibody].
    Tanaka T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():411-4. PubMed ID: 16111288
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of type C fulminant hepatitis by the detection of antibodies to the putative core proteins of hepatitis C virus.
    Yoshiba M; Sekiyama K; Sugata F; Okamoto H
    Gastroenterol Jpn; 1991 Apr; 26(2):234. PubMed ID: 1645689
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C testing--a case of trying to run before we can walk?
    Cossart Y
    Med J Aust; 1994 Jul; 161(2):103. PubMed ID: 8028532
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and virological analysis of the non-A, non-B hepatitis negative for HCV antibody (anti-C-100)].
    Kamimura T; Miyajima T; Okoshi S; Kojima H; Asakura H; Shimotono K
    Nihon Rinsho; 1991 Feb; 49(2):409-11. PubMed ID: 1849201
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunodominant regions of core protein of hepatitis C virus and antibody-assays employing two recombinant core proteins, p22 and JCC4].
    Ohba H; Chiba J; Miyamura T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):212-23. PubMed ID: 7563702
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.
    Pawlotsky JM; Roudot-Thoraval F; Pellet C; Aumont P; Darthuy F; Remire J; Duval J; Dhumeaux D
    J Clin Microbiol; 1995 May; 33(5):1357-9. PubMed ID: 7542272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of hepatitis C related markers and control of hepatitis C infection].
    Yoshizawa H
    Nihon Koshu Eisei Zasshi; 1992 Aug; 39(8):441-4. PubMed ID: 1327295
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
    Gordon EJ; Bhat R; Liu Q; Wang YF; Tackney C; Prince AM
    J Infect Dis; 2000 Jan; 181(1):42-50. PubMed ID: 10608749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of hepatitis C virus infection].
    Mateos M; Teruel JL; Nash R; Fernández Lucas M
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):662. PubMed ID: 1668299
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients.
    Missale G; Cariani E; Lamonaca V; Ravaggi A; Rossini A; Bertoni R; Houghton M; Matsuura Y; Miyamura T; Fiaccadori F; Ferrari C
    Hepatology; 1997 Sep; 26(3):792-7. PubMed ID: 9303515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.